Showing 1 - 20 results of 9,796 for search '(( significantly teer decrease ) OR ( significant changes case ))', query time: 0.39s Refine Results
  1. 1
  2. 2
  3. 3

    Transepithelial electrical resistance (TEER) (N = 6). by Shirko Marcel Shokr (19173337)

    Published 2024
    “…<p><b>(A)</b> During the cultivation of SMC and ALI we observed significantly differences on day 18 (SMC: 9.61 kΩ*cm<sup>2</sup>; ALI: 7.73 kΩ*cm<sup>2</sup>; p<0.05) and day 25 (SMC: 8.19 kΩ*cm<sup>2</sup>; ALI: 6.44 kΩ*cm<sup>2</sup>; p<0.05) ALI cultures showed significantly decreased values compared to SMC. …”
  4. 4
  5. 5
  6. 6

    The qualitative review of significant changed bile acids between case group and control group in different biological samples. by Xu Han (141301)

    Published 2024
    “…<p>The qualitative review of significant changed bile acids between case group and control group in different biological samples.…”
  7. 7
  8. 8
  9. 9
  10. 10

    Statistical significance of contextual response changes. by Benoit Le Bec (13020752)

    Published 2022
    “…Filled bars represent “significant” individual cases (one-sided permutation test, 104 repetitions, p< 0.05). …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  18. 18

    Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  19. 19
  20. 20